Sekar, A, Bialas, AR, de Rivera, H, Davis, A, Hammond, TR, Kamitaki, N, et al. Schizophrenia risk from complex variation of complement component 4. Nature
2016; 530: 177–93.
Singh, T, Kurki, M, Curtis, D, Purcell, S, Cooks, L, McRae, J, et al. Rare SETD1A loss-of-function variants are associated with schizophrenia and developmental disorders. Nat Neurosci
2016; 19: 571–7.
Schizophrenia Working Group of the Psychiatric Genomics Consortium.
Biological insights from 108 schizophrenia-associated genetic loci. Nature
2014; 511: 421–7.
Rees, E, Walters, JTR, Georgieva, L, Isles, AR, Chambert, KD, Richards, AL, et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry
2014; 204: 108–14.
St Clair, D, Blackwood, D, Muir, W, Walker, M, St Clair, D, Muir, W, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet
1990; 336: 13–6.
Takata, A, Xu, B, Ionita-Laza, I, Roos, JL, Gogos, JA, Karayiorgou, M. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene. Neuron
2014; 82: 773–80.
Dincer, A, Gavin, DP, Xu, K, Zhang, B, Dudley, JT, Schadt, EE, et al. Deciphering H3K4me3 broad domains associated with gene-regulatory networks and conserved epigenomic landscapes in the human brain. Transl Psychiatry
2015; 5: e679.
The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium.
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci
2015; 18: 199–209.
Curtis, D. Pathway analysis of whole exome sequence data provides further support for the involvement of histone modification in the aetiology of schizophrenia. Psychiatr Genet